Photo of Sheila Jackson Lee
D United States House · District 18 · Former member · Texas

Rep. Sheila Jackson Lee

Compare
Total votes
2,006
all sessions
Attendance
79%
419 missed
Lower than 99% of chamber peers
With party
98%
of cast votes
Higher than 86% of chamber peers
Bipartisan score
1%
crosses aisle rarely
Lower than 87% of chamber peers
Sponsored
1,479
bills & resolutions
Higher than 87% of chamber peers
Committees
0
assignments
1,479 bills and resolutions

Sponsored bills

Total
1,479
Primary
114
Co-sponsor
1,365
This page
1,479
matching current filters
Co-sponsor HR 2883
In committee · United States House · Co-sponsor
Stop Stalling Access to Affordable Medications

Stop Stalling Access to Affordable Medications This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug. The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.

In committee Sep 29, 2021 1 co-sponsor
Co-sponsor HR 2891
In committee · United States House · Co-sponsor
Preserve Access to Affordable Generics and Biosimilars Act

Preserve Access to Affordable Generics and Biosimilars Act This bill authorizes the Federal Trade Commission (FTC) to initiate proceedings against parties to any agreement resolving or settling a patent infringement claim in connection with the sale of a drug or biological product. Such an agreement is presumed to have anticompetitive effects and is a violation of this bill if the filer of the generic drug or biosimilar application receives anything of value and agrees to limit or forego research, development, manufacturing, marketing, or sales of the generic drug or biosimilar. An agreement is exempted if the only consideration granted to the generic manufacturer is (1) the right to market its product prior to the expiration of any statutory exclusivity, (2) a payment for reasonable litigation expenses, or (3) a covenant not to sue on any claim that the generic drug or biosimilar infringes a patent. An agreement is also exempt if the agreement's pro-competitive benefits outweigh the anticompetitive effects. When a generic or biosimilar drug manufacturer enters into an agreement with another drug manufacturer related to the manufacturing, marketing, or sale of a drug, the manufacturers must certify that the material they have given the FTC concerning the agreement contains the complete agreement and any agreements related to that main agreement, including descriptions of any oral agreements or representations. The bill imposes penalties for violations of this bill, including the forfeiture of the 180-day marketing exclusivity period for a generic drug.

In committee Sep 29, 2021 1 co-sponsor
Co-sponsor HR 1693
Passed · United States House · Co-sponsor
EQUAL Act of 2021

Eliminating a Quantifiably Unjust Application of the Law Act of 2021 or the EQUAL Act of 2021 This bill eliminates the federal sentencing disparity between drug offenses involving crack cocaine and powder cocaine. Currently, different threshold quantities of crack cocaine and powder cocaine (e.g., 28 grams of crack cocaine and 500 grams of powder cocaine) trigger the same statutory criminal penalties. This bill eliminates the lower quantity thresholds for crack cocaine offenses. Under the bill, the same threshold quantities of crack cocaine and powder cocaine trigger the same statutory criminal penalties. The change applies to future cases and cases pending on the date of enactment. With respect to past cases, the bill authorizes a sentencing court to impose a reduced sentence on a defendant who was convicted or sentenced for a specified crack cocaine offense before this bill's enactment. A defendant does not have to be present at the sentence reduction hearing. Finally, the bill prohibits the reduction of a sentence that was previously reduced.

Passed Sep 29, 2021 1 co-sponsor
Co-sponsor HRES 685
In committee Sep 28, 2021 1 co-sponsor
Co-sponsor HR 5342
In committee · United States House · Co-sponsor
Tyler Clementi Higher Education Anti-Harassment Act of 2021

Tyler Clementi Higher Education Anti-Harassment Act of 2021 This bill addresses harassment at institutions of higher education (IHEs). Specifically, the bill requires each IHE to include in its annual security report a statement of policy regarding harassment on the basis of a student's actual or perceived race, color, national origin, sex (including sexual orientation, gender identity, pregnancy, childbirth, a medical condition related to pregnancy or childbirth, and a sex stereotype), disability, or religion. In addition, the Department of Education may award grants to IHEs to initiate, expand, or improve programs to (1) prevent the harassment of students; (2) provide counseling or redress services to students who have been harassed or accused of subjecting other students to harassment; or (3) educate and train students, faculty, or staff to prevent harassment or address harassment if it occurs.

In committee Sep 22, 2021 1 co-sponsor
Co-sponsor HR 5307
In committee · United States House · Co-sponsor
Keeping Renters Safe Act of 2021

Keeping Renters Safe Act of 2021 This bill expressly authorizes the Department of Health and Human Services (HHS) to place a moratorium on residential evictions to prevent the spread of communicable diseases. The bill also requires HHS to implement a moratorium nationwide to reduce the spread of COVID-19. This moratorium must remain in effect for at least 60 days following the termination of the COVID-19 public health emergency. Current law authorizes HHS to take measures to prevent the spread of communicable diseases. As part of the COVID-19 response, HHS delegated this authority to the Centers for Disease Control and Prevention (CDC), which then issued (and extended) several orders banning residential evictions. Whether these orders exceed the CDC's statutory and constitutional authority has been the subject of multiple legal challenges; the Supreme Court blocked enforcement of the most recent order on August 26, 2021.

In committee Sep 22, 2021 1 co-sponsor
Co-sponsor HR 5285
In committee · United States House · Co-sponsor
Extend Unemployment Assistance Act of 2021

Extend Unemployment Assistance Act of 2021 This bill extends pandemic unemployment compensation provisions set to expire on September 6, 2021, until February 1, 2022. Extended provisions include benefits to covered individuals who are not eligible for regular unemployment compensation or traditional extended benefits, the $300 weekly benefit increase, waiting week benefits, and federal reimbursement of short-time compensation. The bill also increases the maximum duration of compensation from 79 weeks to 100 weeks.

In committee Sep 17, 2021 1 co-sponsor
Co-sponsor HR 5247
In committee · United States House · Co-sponsor
Reducing Obesity in Youth Act of 2021

Reducing Obesity in Youth Act of 2021 This bill requires the Centers for Disease Control and Prevention, in coordination with the Administration for Children and Families, to award grants to nonprofits, institutions of higher education, or consortia of these entities to promote healthy eating and physical activity and address food insecurity among children in early care and education settings.

In committee Sep 15, 2021 1 co-sponsor
Showing 1,051 to 1,060 of 1,479 bills